Beyond circles and squares: A commentary on updating pedigree nomenclature to better represent patient diversity.

access attitudes communication community cultural competence disparities diversity education family history gender minorities genetic counseling genetics services intersex non-binary pedigree nomenclature psychosocial transgender underrepresented populations

Journal

Journal of genetic counseling
ISSN: 1573-3599
Titre abrégé: J Genet Couns
Pays: United States
ID NLM: 9206865

Informations de publication

Date de publication:
06 2020
Historique:
received: 27 11 2019
revised: 06 02 2020
accepted: 07 02 2020
pubmed: 28 2 2020
medline: 9 2 2021
entrez: 28 2 2020
Statut: ppublish

Résumé

With changes in our understanding of gender identity and disorders of sex differentiation (DSDs), as well as a need to promote medical care that appropriately reflects the intersectional personal identities of patients with respect to sex and gender, we explored possible modifications of pedigree nomenclature to better represent such patient diversity. There are currently no widely accepted standard symbols to simultaneously represent both gender identity and assigned sex at birth within a pedigree. Previous studies assessing perspectives from members of the transgender and gender non-binary (TGNB) community have highlighted the need for a unique symbol to represent non-binary individuals and better ways to represent core gender identities for gender minorities such as transgender individuals. In our experience we have encountered similar dilemmas with documentation for individuals with DSDs in terms of a lack of unequivocal symbolic representation within the pedigree. Here we propose three distinct symbols for gender identity combined with superscript symbols to represent sex assigned at birth, which we think may unequivocally represent TGNB individuals and patients with DSDs. It is clear that further research is needed to ensure that any proposed changes are acceptable by and respectful of all patients regardless of their gender identity and assigned sex at birth. We hope that further research will include focus groups and surveys to get broader input from gender minority stakeholders so that new standards can be developed and modified as we strive to meet the needs of our increasingly diverse patient population.

Identifiants

pubmed: 32103563
doi: 10.1002/jgc4.1234
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

435-439

Informations de copyright

© 2020 National Society of Genetic Counselors.

Références

Barnes, H., Morris, E., & Austin, J. (2019). Trans-inclusive genetic counseling services: Recommendations from members of the transgender and non-binary community. Journal of Genetic Counseling, 00, 1-12. https://doi.org/10.1002/jgc4.1187
Bennett, R. L., French, K. S., Resta, R. G., & Doyle, D. L. (2008). Standardized human pedigree nomenclature: Update and assessment of the recommendations of the national society of genetic counselors. Journal of Genetic Counseling, 17(5), 424-433. https://doi.org/10.1007/s10897-008-9169-9
Berro, T., Zayhowski, K., Field, T., Channaoui, N., & Sotelo, J. (2019). Genetic counselors’ comfort and knowledge of cancer risk assessment for transgender patients. Journal of Genetic Counseling, 00, 1-10. https://doi.org/10.1002/jgc4.1172
GLAAD (2011). GLAAD media reference guide-transgender. Retrieved from https://www.glaad.org/reference/transgender
Provenzale, D., Gupta, S., Regenbogen, S. E., Hampel, H., Slavin, T. P., Hall, M. J. … Ogba, N. (2017). National Comprehensive Cancer Network: Genetic/familial high-risk assessment: Colorectal, 3.2017.
UCSF Center of Excellence for Transgender Health (2016). Terminology and definitions. Retrieved from http://transhealth.ucsf.edu/trans?page=guidelines-terminology
Zayhowski, K., Park, J., Boehmer, U., Gabriel, C., Berro, T., & Campion, M. (2019). Cancer genetic counselors’ experiences with transgender patients: A qualitative study. Journal of Genetic Counseling, 28(3), 641-653. https://doi.org/10.1002/jgc4.1092

Auteurs

Allysa Tuite (A)

Division of Clinical Genetics, Department of Pediatrics, Rutgers New Jersey Medical School, Newark, NJ, USA.

Michelle Dalla Piazza (M)

Division of Infectious Disease, Department of Medicine, Rutgers New Jersey Medical School, Newark, NJ, USA.

Kristyn Brandi (K)

Department of Obstetrics, Gynecology, and Women's Health, Rutgers New Jersey Medical School, Newark, NJ, USA.

Beth A Pletcher (BA)

Division of Clinical Genetics, Department of Pediatrics, Rutgers New Jersey Medical School, Newark, NJ, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH